KEYW Holding serves corporations and the military in a number of ways. Read More
Archive
Filter
Seres addresses antibiotic-resistant bacteria and other diseases. Read More
When we launched Breakthrough Tech Profits two months ago, we knew our stock picks were good, but we also thought our timing was, too. We expected a flood of investor money would soon flow into technology-intensive companies that could generate bigger profits in a stagnant global economy. Still, we didn’t… Read More
Shares of Medidata Solutions (Nasdaq: MDSO), the leading cloud analytic software company for the biotech research space, rallied after beating earnings expectations by one cent and reaffirming its forward guidance. The company reported results of Q2 EPS of $0.24, versus expectations of $0.23. Revenue for the quarter came in at… Read More
It wasn’t long ago that investors couldn’t run away from Western Digital (WDC) fast enough. The darling of contrarian tech investors only two years ago as its share price soared above $100, rapidly declining sales of PCs during the past year and concerns over the price Western Digital paid to… Read More
I’m not going to lie; I have absolutely no idea what a Pokémon is aside from some sort of cartoonish character used in a popular video game. Judging from my newsfeed nothing else has happened in the world since the augmented reality game Pokémon Go was released earlier this month,… Read More
This could be the final boarding call for buyers of Ambarella Inc. (Nasdaq: AMBA), a global leader in high-speed video chip technology, as the stock is approaching the top of our recommended buy range of $57 and looks ready to make its way toward the $60-plus area. Turnaround ProceedsI like Ambarella’s… Read More
In the inaugural issue of Breakthrough Tech Profits, I recommended disk drive manufacturer Western Digital (WDC) as a play on growth in the SSD (solid state drive) market due to its recent acquisition of SanDisk. Although I felt the benefits from that transaction would be realized sooner than most… Read More
It’s time to take profits on the McKesson January 19, 2018 195 LEAPS Call option (MCK_011918C195) after a major gain. I recommended its purchase on May 26, 2016 and the long term option gained 43.9% as of the close of trading on July 14, based on the entry price of… Read More
Juno Therapeutics (Nasdaq: JUNO), a company specializing in immunotherapy combined with chemotherapy and conventional cancer treatments, was rallying in early trading today, just five days after a massive 30 plus percent drop in price after two unexpected deaths occurred in a critical Phase II trial for end stage leukemia patients… Read More